Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

NCT06316856

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT06059391

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +34 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • DFCI/BWH Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

NCT06173518

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +24 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Methodist Children's Hospital San Antonio, Texas, United States
  • Primary Children's Hospital Salt Lake City, Utah, United States
  • Hospital Vall d'Hebron Barcelona, Spain
View Trial Details

Related conditions